Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

Fig. 3

Immunofluorescence microscopy of cytochrome c oxidase (CCO). Liver tissues obtained after 6-month treatment with vehicle or metformin were stained with anti-CCO (green). The CCO staining was weak and uniform in Zucker lean rats, whereas Zucker diabetic fatty rats showed patched of strong CCO reactivity. Stronger CCO labeling was seen at the intracellular vacuoles in hepatocytes with ballooning degeneration from metformin-treated rats (ZDF + metformin-1, (ZDF + metformin-2)

Back to article page